Cargando…

Oncology approvals in 2020: a year of firsts in the midst of a pandemic

In 2020, despite challenges related to the COVID-19 pandemic, the US FDA approved 30 new drugs and biologic agents, 45 supplemental drug and biologic applications and 1 biosimilar application in oncology.

Detalles Bibliográficos
Autores principales:	Amiri-Kordestani, Laleh, Pazdur, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844812/ https://www.ncbi.nlm.nih.gov/pubmed/33514911 http://dx.doi.org/10.1038/s41571-021-00477-1

Ejemplares similares

Approvals in 2021: dangling Accelerated Approvals, drug dosing, new approvals and beyond
por: Lemery, Steven, et al.
Publicado: (2022)

2020 International Year of Midwifery—In the midst of a pandemic
por: Furuta, Marie
Publicado: (2020)

Wakley Prize Essay 2020: medicine and plain truths in a pandemic year
por: Boyce, Niall, et al.
Publicado: (2020)

US Food and Drug Administration regulatory updates in neuro-oncology
por: Mehta, Gautam U., et al.
Publicado: (2021)

Oncology Drug Approvals: Evaluating Endpoints and Evidence in an Era of Breakthrough Therapies
por: Blumenthal, Gideon M., et al.
Publicado: (2017)

Building biorepositories in the midst of a pandemic
por: Croker, Jennifer A., et al.
Publicado: (2021)

Public health, pandemic response, and the 2020 US election
por: Choo, Esther K, et al.
Publicado: (2020)

Final approval for corticosteroids in severe CAP? For sure, in septic shock
por: Martin-Loeches, Ignacio, et al.
Publicado: (2023)

Avoiding collateral mortality in a pandemic — time to change our mindset in surgical oncology
por: Tan, Ker-Kan, et al.
Publicado: (2020)

The scientific production during 2009 swine flu pandemic and 2019/2020 COVID-19 pandemic
por: Carvalho, T.A., et al.
Publicado: (2020)

Challenges of globalization of cancer drug trials- recruitment in LMICs, approval in HICs
por: Gyawali, Bishal, et al.
Publicado: (2021)

Medical education in the midst of pandemic and beyond
por: Mejicano, George, et al.
Publicado: (2021)

Mindfulness moments for clinicians in the midst of a pandemic
por: Hedderman, E., et al.
Publicado: (2020)

The impact of the first 2 years of the COVID-19 pandemic on breast cancer diagnoses: a population-based study in England
por: Gathani, Toral, et al.
Publicado: (2022)

Assessing cardiac safety in oncology drug development
por: Seltzer, Jonathan H, et al.
Publicado: (2019)

The Wakley–Wu Lien Teh Prize Essay 2020: Chinese health workers' experiences during the COVID-19 pandemic
por: Wang, Helena Hui, et al.
Publicado: (2020)

Additional consensus recommendations for conducting complex innovative trials of oncology agents: a post-pandemic perspective
por: Blagden, Sarah P., et al.
Publicado: (2022)

Confronting antimicrobial resistance beyond the COVID-19 pandemic and the 2020 US election
por: Strathdee, Steffanie A, et al.
Publicado: (2020)

Frailty Assessment in Clinical Practice: Opportunity in the Midst of a Pandemic
por: Keevil, Victoria L., et al.
Publicado: (2020)

Review on the Oncology Practice in the Midst of COVID-19 Crisis: The Challenges and Solutions
por: Fadavi, Pedram, et al.
Publicado: (2021)

A COVID-19 conference at AIDS 2020: Virtual
por: Pozniak, Anton, et al.
Publicado: (2020)

Incidence and determinants of maternal sepsis in Ghana in the midst of a pandemic
por: Noora, Charles Lwanga, et al.
Publicado: (2022)

Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations
por: Issa, Amalia M., et al.
Publicado: (2018)

LEGIONELLA INFECTION IN THE MIDST OF COVID-19 PANDEMIC
por: GANDHI, KEJAL, et al.
Publicado: (2021)

Sexually Transmitted Diseases in the Midst of the Coronavirus Pandemic
por: Krau, Stephen D.
Publicado: (2020)

Systematic Review of PD‐1/PD‐L1 Inhibitors in Oncology: From Personalized Medicine to Public Health
por: Chang, Elaine, et al.
Publicado: (2021)

In the Midst of Life
Publicado: (1888)

Sustaining primary care teams in the midst of a pandemic
por: Sullivan, Erin E., et al.
Publicado: (2020)

Medical education in the midst of the coronavirus (COVID-19) pandemic-one year later
por: Alsafi, Zaid, et al.
Publicado: (2021)

Commentary: the first twelve years of the Journal of chemoinformatics
por: Willett, Peter
Publicado: (2022)

Comment: Head and Neck Oncology
Publicado: (2014)

Crowdsourcing a crisis response for COVID-19 in oncology
por: Desai, Aakash, et al.
Publicado: (2020)

Digital Orthopaedics: A Glimpse Into the Future in the Midst of a Pandemic
por: Bini, Stefano A., et al.
Publicado: (2020)

FDA Approval Summary: Brentuximab Vedotin in First‐Line Treatment of Peripheral T‐Cell Lymphoma
por: Richardson, Nicholas C., et al.
Publicado: (2019)

The role of Colombian psychiatrists in the midst of the COVID-19 pandemic()
por: Cano, Juan Fernando, et al.
Publicado: (2021)

Surgery for pancreatic tumors in the midst of COVID-19 pandemic
por: Kato, Hiroyuki, et al.
Publicado: (2021)

Data Versus Truth in the Midst of the COVID-19 Pandemic
por: Rohrer, Jim
Publicado: (2020)

The work identity of leaders in the midst of the COVID-19 pandemic
por: Meadows, Stephanie, et al.
Publicado: (2022)

580 Burn Camp in the Midst of the COVID-19 Pandemic
por: ONeill, Keisha, et al.
Publicado: (2023)

Microbes and microbiomes in 2020 and beyond
por: Natarajan, Aravind, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lm9tgtg9v1prkgj5qbokkvbnrv